chevron_leftBack
As of 15 June 2026, HARBIN GLORIA PHARMACEUTICALS Co., LTD. has a market cap of $1.16B USD, ranking #9884 globally and #2725 in China.
It ranks #863 in the Healthcare sector, and #324 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.16BUSD
7.85B CNY
Enterprise Value
$1.03BUSD
6.94B CNY
Revenue (TTM)
$313.36MUSD
2.12B CNY
Net Income (TTM)
$60.74MUSD
411.58M CNY
Profit Margin
19%
PE Ratio
19.1
PS Ratio
3.7
PB Ratio
3.3
EV/EBITDA
22.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Leifeng Guo
open_in_new
Employees
2,703
Founded
2000
Website
gloria.cc
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -2.8% | -3.6% | 4.5% | 1.1% | 5.4% | 42% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
002437
哈尔滨誉衡药业股份有限公司 Class A
ISIN: CNE100000QG8
Shares Out.:
Shares Outstanding:
2.062B1
Shares Float:
1.599B2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
3.52 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About HARBIN GLORIA PHARMACEUTICALS Co., LTD.
HARBIN GLORIA PHARMACEUTICALS Co., LTD engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. Its products include cardiovascular and cerebrovascular, musculoskeletal, vitamins, electrolyte, diabetes-lowering, analgesics, digestive system and metabolism, anti-infective, and anti-tumor drugs. Harbin Gloria Pharmaceuticals Co., Ltd was founded in 2000 and is based in Harbin, the People’s Republic of China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
5K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
4K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
2K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
2K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
1K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
1K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
66K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
47K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
31K%
|
97.4
|
|
SIX: RO
|
$321.52B
28K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
25K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
24K%
218.9B CHF
|
20.5
|
chevron_leftBack